Results 91 to 100 of about 101,964 (348)
Ultimobranchial Calcitonin in the Developing Chicken [PDF]
Peter B. Dent +2 more
openalex +1 more source
GLP‐1 Receptor Agonists for Obstructive Sleep Apnea: An Otolaryngologist's Prescription?
The Laryngoscope, EarlyView.
Alina Zgardau +3 more
wiley +1 more source
Abstract Objective To assess the potential prognostic role of sonographic parameters such as glenohumeral joint effusion, subacromial‐subdeltoid bursitis, and the type of intratendinous calcific deposition to predict the clinical and functional outcomes of focal extracorporeal shockwave therapy (fESWT) in patients with calcific tendinopathy of the ...
Arianna Pesaresi +6 more
wiley +1 more source
Reports on the coexistence of diabetes mellitus and osteoarthritis in human subjects dated back to the 1960s. However, there is no account in literature on the co-manifestation of these disease conditions in experimental animals.
Wale J Adeyemi, Luqman A Olayaki
doaj +1 more source
Abstract Background Pain is often observed in patients with spasticity, but little is known about the relationship between pain and spasticity and the effectiveness of treating pain with botulinum toxins in these patients. Objective To explore onabotulinumtoxinA (onabotA) use and pain relief in patients with spasticity with pain at baseline.
Jörg Wissel +5 more
wiley +1 more source
Comparison of Different Treatment Protocols in Postmenopausal Osteoporosis
This study was planned to compare the effects of three different treatment protocols including calcitonin, calcium and Vit D on bone mineral density (BMD) of postmenauposal women.
Mehmet Portakal +4 more
doaj
ABSTRACT Allergic rhinitis (AR) is a chronic inflammatory disease of the nasal mucosa characterized by allergen sensitization and the involvement of multiple inflammatory mediators. Currently, the treatment of AR mainly includes symptomatic relief, anti‐inflammatory therapy, and nerve desensitization. However, these treatments have limitations in fully
Yue Gu +7 more
wiley +1 more source
ABSTRACT Nemolizumab, an anti‐interleukin‐31 receptor A monoclonal antibody, has been approved in Japan for treating atopic dermatitis (AD)‐associated pruritus. While it is effective for itch control, nemolizumab‐associated cutaneous adverse events have been increasingly recognized, yet their clinical features remain poorly characterized. In this study,
Wataru Sasaki +24 more
wiley +1 more source
Salmon calcitonin-induced stimulation of 1α,25-dihydroxycholecalciferol synthesis in rats involving a mechanism independent of adenosine 3′:5′-cyclic monophosphate [PDF]
Noboru Horiuchi +6 more
openalex +1 more source

